68 results found
ট্রাস্ট-এর অধীনে মার্কিন-ভারত বায়োটেক সহযোগিতা শুধু এক�
कृत्रिम बुद्धिमत्ता (AI) जागतिक औषध शोध क्षेत्रात आमूलाग्�
India’s first indigenous CRISPR therapy, Birsa-101, signals a decisive shift toward affordable gene-editing solutions for Sickle-cell Disease
AI is transforming global drug discovery. As China races ahead and the US recalibrates, India must harness its talent and data to drive pharma innovat
The US-India biotech collaboration under TRUST is more than a bilateral game; it can help reshape global value chains and promote inclusive, ethical i
চিন যখন বিশ্বব্যাপী প্রভাবযুক্ত জৈবপ্রযুক্তি উদ্ভাবনে�
Rising US-China tensions over biosecurity and chemical threats create risks and opportunities for India to strengthen its role in global biotech and s
One year on, as India’s BioE3 policy lays the groundwork for a US$300 billion bioeconomy, its success hinges on closing gaps in talent, scale-up, an
As China scales biotech innovation with global impact, India must act fast to secure its place in a field as strategic as it is scientific.
CRISPR-based biosensors provide an innovative point-of-use solution to tackle the increasing threat of foodborne illnesses and for research and develo
.jpg)
India’s growing biomedical plastic waste stream remains largely excluded from circular economy planning, particularly in healthcare systems beyond h
लोकसंख्येचे वय जसजसे वाढत जाते, तसतसे देश त्यांचा प्रभाव
जैसे-जैसे उम्रदराज़ लोगों की संख्या बढ़ रही है, वैसे-वैसे
As aging populations grow, nations turn to longevity diplomacy—using health policies, biotech, and therapeutics to enhance soft power and global lea
अमेरिकेच्या निर्बंधांनी अनवधानाने चीनला संशोधन व विकास
अमेरिकी प्रतिबंधों ने अनायास ही चीन को अपने अनुसंधान व व�
The US restrictions have inadvertently spurred China to accelerate R&D and innovation, allowing it to challenge Western dominance
एंटीबायोटिक प्रतिकारशक्तीची गुंतागुंतीची समस्या केवळ �
The complex problem of antimicrobial resistance needs to be combated with a coordinated strategy, supported by governmental and cross-sector collabora
The collaboration between space research and biotechnology can both improve the health of space travellers and also aid with new research and innovati
मानसिक आरोग्यविषयक संकटाशी प्रभावीपणे सामना करण्यासाठ�
India must prioritise the development of novel drugs to address the mental health crisis effectively, leveraging its biotechnology and pharmaceutical
There is a growing need to harness miRNA biology to develop new technologies and focus on its translational applications
अमेरिकेचा बायोसिक्युअर कायदा त्या देशाच्या चीनशी असलेल
जैवतंत्रज्ञानाच्या प्रगतीमधली गुंतागुंत आणि संभाव्य ज�
‘आयसीईटी’अंतर्गत बायोसिक्युरिटी आणि बायोसेफ्टी या दोह�
Given the complexity and potential risks associated with the biotechnological advancements, India should establish a dedicated biosecurity agency to a
The US Biosecure Act aims to decouple its supply chains from China, presenting a huge opportunity for India’s pharma industry
Enhanced collaboration between the US and India on biosecurity and biosafety under iCET could be highly advantageous
.png)
Advancements in biotechnology and accessible dual-use technologies have raised concerns about non-state actors gaining unregulated access to biologica
চিন–রাশিয়া জৈবপ্রযুক্তি সহযোগিতা, যা ফার্মাসিউটিক্যা�
चीनी-रशियन बायोटेक्नॉलॉजीच्या सहकार्यामुळे फार्मास्य�
कृत्रिम बुद्धिमत्ता (AI) आणि जैवतंत्रज्ञान यांच्यातील सम�
फार्मास्यूटिकल्स और आर्थिक वृद्धि पर रणनीतिक ज़ोर के बू�
The Sino-Russian biotechnology collaboration, augmented by its strategic focus on pharmaceuticals and economic growth, has called for a global concern
While addressing aspects of the synergy between Artificial Intelligence (AI) and biotechnology, the existing regulatory landscape will need more expli
जैसे जैसे जैव प्रौद्योगिकी का उद्योग विकसित हो रहा है, वै�
As the biotechnology industry evolves, integrating synthetic data and model-based reasoning will remain crucial for addressing complex biological chal
As genetic engineering continues to grow and find more avenues of impact, the need to optimise and regulate this technology will also heighten
Indian tech startups are confronting huge roadblocks as funding runs low
अपनी स्थापना के साथ ही जैव प्रौद्योगिकी विभाग ने खुद को स�
As the ecosystem evolves and companies mature, there are dire requirements for the next phase of innovation driven growth.
Since its inception, DBT has been committed to delivering solutions for societal challenges with a focus on Make in India.
Saudi Arabia and the UAE are making strides in biotechnology and digital health, investing heavily in genomics and AI, even as further research capacity and robust data governance remain essential.
Advances in disruptive technologies have enabled scientists to engineer biological systems and create more efficient and sustainable products for a range of purposes. The convergence of artificial intelligence (AI) with biotechnology has contributed to the development of therapeutics and vaccines, helped address food security, aided in generating innovative processes to mitigate the effects of climate change, and expanded the bioeconomy. However,
This brief analyses the regulatory, security and ethical challenges facing states and the international community regarding emerging technologies in biotechnology, focusing on the CRISPR/Cas9 gene editing system and artificial gene synthesis. It highlights the inadequacy of current mechanisms such as export control regimes to regulate these emerging technologies because of a fundamental shift in the nature of challenges posed and an altered globa
